View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Diabetes News

SPONSORED CONTENT
November 20, 2024
1 min read
Save
Top in endocrinology: Daily oral semaglutide for weight loss; intuitive eating

Top in endocrinology: Daily oral semaglutide for weight loss; intuitive eating

Results from the OASIS 4 trial revealed that people with overweight or obesity assigned to once-daily oral semaglutide had a higher likelihood of significant weight loss compared with those receiving placebo plus lifestyle intervention.

SPONSORED CONTENT
November 19, 2024
2 min read
Save

Telemedicine-supported low-carb diet linked to type 2 diabetes remission, weight loss

Telemedicine-supported low-carb diet linked to type 2 diabetes remission, weight loss

A telemedicine-based nutrition counselling program emphasizing a low-carbohydrate diet resulted in sustained diabetes remission over half a decade for some individuals with type 2 diabetes, results of an open-label study showed.

SPONSORED CONTENT
November 18, 2024
2 min read
Save

Food access in formerly redlined neighborhoods tied to poor cardiometabolic health

Food access in formerly redlined neighborhoods tied to poor cardiometabolic health

CHICAGO — People living in historically redlined neighborhoods with poor access to healthy foods were more likely to have type 2 diabetes, hypertension, coronary heart disease and obesity, researchers reported.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
November 16, 2024
3 min read
Save

Lower is better: BPROAD trial backs intensive blood pressure target for patients with diabetes

Lower is better: BPROAD trial backs intensive blood pressure target for patients with diabetes

CHICAGO — An intensive blood pressure strategy resulted in a lower incidence of major cardiovascular events compared with a more standard strategy among patients with type 2 diabetes and elevated systolic blood pressure in the BPROAD trial.

SPONSORED CONTENT
November 14, 2024
3 min read
Save

Diabetes inequities persist worldwide, especially for low-, middle-income countries

Diabetes inequities persist worldwide, especially for low-, middle-income countries

From 1990 to 2022, diabetes prevalence rose greatly, but for the most part, treatment did not increase at all or sufficiently, especially in low- and middle-income countries, researchers reported in The Lancet.

SPONSORED CONTENT
November 12, 2024
2 min read
Save

Income may factor into mortality risk among adults with type 2 diabetes

Income may factor into mortality risk among adults with type 2 diabetes

Low income corresponded with a higher risk for death among individuals with type 2 diabetes, a South Korean-based cohort analysis published in JAMA Network Open suggested.

SPONSORED CONTENT
November 08, 2024
4 min read
Save

Swallowable capsule that expands in stomach shows weight-loss, cardiometabolic benefit

Swallowable capsule that expands in stomach shows weight-loss, cardiometabolic benefit

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.

SPONSORED CONTENT
November 06, 2024
2 min read
Save

Top in endocrinology: Sotagliflozin rejected by FDA; new lifestyle intervention guidelines

Top in endocrinology: Sotagliflozin rejected by FDA; new lifestyle intervention guidelines

Sotagliflozin was not recommended for approval by the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee for glucose control as an adjunct to insulin in adults with type 1 diabetes and chronic kidney disease..

SPONSORED CONTENT
November 06, 2024
3 min read
Save

Q&A: Time-restricted eating can have a 'meaningful impact' on metabolic syndrome

Q&A: Time-restricted eating can have a 'meaningful impact' on metabolic syndrome

Time-restricted eating can improve the health of individuals with metabolic syndrome, who are on the precipice of type 2 diabetes, heart disease and other health complications, according to an expert.

SPONSORED CONTENT
November 05, 2024
5 min read
Save

Tirzepatide safe, effective for weight loss, preventing diabetes progression at 3 years

Tirzepatide safe, effective for weight loss, preventing diabetes progression at 3 years

SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails